Conclusions
We present findings from a national registry of hospital EDs on patients with (and without) HIV who presented to US EDs with a suspected SARS-CoV-2 infection. We expectedly find that patients with SARS-CoV-2 fare worse than those without SARS-CoV-2. However, we do not find worse outcomes for patients with both SARS-CoV-2 and HIV compared with those with SARS-CoV-2 but without HIV.
Acknowledgments
The RECOVER Investigators Group: Thomas Aufderheide, MD, Medical College of Wisconsin, Milwaukee, WI; Joshua Baugh, MD, Massachusetts General Hospital, Boston, MA; David Beiser, MD, University of Chicago School of Medicine, Chicago, IL; Christopher Bennett, MD, Stanford University School of Medicine, Palo Alto, CA; Joseph Bledsoe, MD, Healthcare Delivery Institute, Intermountain Healthcare, Salt Lake City, UT; Carlos A. Camargo, MD, DrPH, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Edward Castillo, PhD, University of California at San Diego, San Diego, CA; Makini Chisholm-Staker, MD, Mt. Sinai School of Medicine, New York, NY; D. Mark, Courtney, MD, University of Texas Southwestern, Dallas, TX; Elizabeth Goldberg, MD, Warren Alpert Medical School of Brown University, Providence, RI; Hans House, MD, University of Iowa School of Medicine, Iowa City, IA; Stacey House, MD, Washington University School of Medicine, St. Louise, MO; Timothy Jang, MD, David Geffen School of Medicine at UCLA, Los Angeles, CA; Christopher Kabrhel, MD, Massachusetts General Hospital, Boston, MA; Jeffrey A. Kline, MD, Indiana University School of Medicine, Indianapolis, IN; Stephen Lim, MD, Louisiana State University School of Medicine, New Orleans, New Orleans, LA; Troy Madsen, MD, University of Utah School of Medicine, Salt Lake City, UT; Danielle McCarthy, MD, Northwestern University, Feinberg School of Medicine, Chicago, IL; Andrew Meltzer, MD, George Washington University School of Medicine, Washington, DC, DC; Stephen Moore, MD, Penn State Milton S. Hershey Medical Center, Hershey, PA; Mark B. Mycyk, MD, Department of Emergency Medicine, Cook County Health, Chicago, IL; Craig Newgard, MD, Oregon Health and Science University, Portland, OR; Kristen E. Nordenholz, MD, University of Colorado School of Medicine, Aurora, CO; Justine Pagenhardt, MD, West Virginia University School of Medicine, Morgantown, WV; Ithan Peltan, MD, Intermountain Healthcare, Salt Lake City, UT; Katherine L. Pettit, MD, Indiana University School of Medicine, Indianapolis, IN; Michael Pulia, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI; Michael Puskarich, MD, Hennepin County Medical Center and the University of Minnesota, Minneapolis, MN; Lauren T. Southerland, MD, Ohio State University Medical Center, Columbus, OH; Scott Sparks, MD, Riverside Regional Medical Center, Newport News, VA; Danielle Turner-Lawrence, MD, Beaumont Health, Royal Oak, MI; Marie Vrablik, MD, University of Washington School of Medicine, Seattle, WA; Alfred Wang, MD, Indiana University School of Medicine, Indianapolis, IN; Anthony Weekes, MD, Atrium Health, Charlotte, NC; Lauren Westafer, MD, Baystate Health, Springfield, MA; and John Wilburn, MD, Wayne State University School of Medicine, Detroit, MI.
J Acquir Immune Defic Syndr. 2021;88(4):406-413. © 2021 Lippincott Williams & Wilkins